Barclays’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-535,506
Closed -$45.5M 3802
2020
Q3
$45.5M Buy
535,506
+255,546
+91% +$21.7M 0.03% 287
2020
Q2
$9.92M Sell
279,960
-46,320
-14% -$1.64M 0.01% 663
2020
Q1
$4.4M Sell
326,280
-86,716
-21% -$1.17M ﹤0.01% 937
2019
Q4
$8.74M Buy
412,996
+157,743
+62% +$3.34M ﹤0.01% 910
2019
Q3
$3.38M Buy
255,253
+116,027
+83% +$1.54M ﹤0.01% 1345
2019
Q2
$1.93M Buy
139,226
+38,089
+38% +$528K ﹤0.01% 1840
2019
Q1
$1.94M Sell
101,137
-68,376
-40% -$1.31M ﹤0.01% 1582
2018
Q4
$2.42M Sell
169,513
-286,692
-63% -$4.09M ﹤0.01% 1257
2018
Q3
$9.5M Buy
456,205
+121,519
+36% +$2.53M 0.01% 783
2018
Q2
$7.92M Buy
334,686
+6,459
+2% +$153K 0.01% 822
2018
Q1
$4.8M Buy
328,227
+66,491
+25% +$971K ﹤0.01% 934
2017
Q4
$4.23M Buy
261,736
+255,516
+4,108% +$4.13M ﹤0.01% 936
2017
Q3
$87K Sell
6,220
-67,925
-92% -$950K ﹤0.01% 2747
2017
Q2
$655K Sell
74,145
-35,077
-32% -$310K ﹤0.01% 1777
2017
Q1
$706K Sell
109,222
-19,855
-15% -$128K ﹤0.01% 1769
2016
Q4
$474K Buy
129,077
+113,861
+748% +$418K ﹤0.01% 1856
2016
Q3
$50K Buy
15,216
+1,325
+10% +$4.35K ﹤0.01% 2720
2016
Q2
$32K Sell
13,891
-297,025
-96% -$684K ﹤0.01% 2709
2016
Q1
$622K Buy
310,916
+147,790
+91% +$296K ﹤0.01% 1625
2015
Q4
$489K Buy
163,126
+134,095
+462% +$402K ﹤0.01% 1701
2015
Q3
$30K Sell
29,031
-120,459
-81% -$124K ﹤0.01% 2746
2015
Q2
$598K Buy
149,490
+16,485
+12% +$65.9K ﹤0.01% 1700
2015
Q1
$399K Buy
133,005
+22,903
+21% +$68.7K ﹤0.01% 2024
2014
Q4
$440K Buy
110,102
+58,427
+113% +$233K ﹤0.01% 2053
2014
Q3
$155K Sell
51,675
-1,148
-2% -$3.44K ﹤0.01% 2426
2014
Q2
$158K Sell
52,823
-40,133
-43% -$120K ﹤0.01% 2506
2014
Q1
$373K Buy
92,956
+58,803
+172% +$236K ﹤0.01% 2099
2013
Q4
$137K Buy
34,153
+27,646
+425% +$111K ﹤0.01% 2854
2013
Q3
$39K Buy
6,507
+432
+7% +$2.59K ﹤0.01% 3287
2013
Q2
$33K Buy
+6,075
New +$33K ﹤0.01% 3514